TABLE 3.
Sample Attrition for Subset of Patients Included in the Mixed Model Analyses
| No. Patients N (% of Original) | ||||
|---|---|---|---|---|
| Clinical Outcomes | Attrition Step | MPM (Original N=161), n (%) | MPP (Original N=146), n (%) | WHT+MPP (Original N=105), n (%) |
| PHQ-9 | Baseline measurement within 6-mo before the index date | 62 (38.5) | 105 (71.9) | 69 (65.7) |
| At least 2 measurements during the study period | 62 (38.5) | 105 (71.9) | 69 (65.7) | |
| Baseline measurement above clinical threshold | 31 (19.3) | 75 (51.4) | 33 (31.4) | |
| NRS | Baseline measurement within 6-mo before the index date | 148 (91.9) | 146 (100) | 89 (84.8) |
| At least 2 measurements during the study period | 148 (91.9) | 146 (100) | 89 (84.8) | |
| Baseline measurement above clinical threshold | 139 (86.3) | 135 (92.5) | 79 (75.2) | |
| ODI back | Baseline measurement within 6-m before the index date | 37 (23) | 81 (55.5) | 58 (55.2) |
| At least 2 measurements during the study period | 37 (23) | 81 (55.5) | 58 (55.2) | |
| Baseline measurement above clinical threshold | 36 (22.4) | 80 (54.8) | 54 (51.4) | |
| ODI neck | Baseline measurement within 6-mo before the index date | 27 (16.8) | 59 (40.4) | 35 (33.3) |
| At least 2 measurements during the study period | 27 (16.8) | 59 (40.4) | 35 (33.3) | |
| Baseline measurement above clinical threshold | 27 (16.8) | 58 (39.7) | 35 (33.3) | |
| MME | 12 mo EHR activity after the index date | 154 (95.7) | 144 (98.6) | 79 (75.2) |
| Baseline measurement within 6-mo before the index date | 154 (95.7) | 144 (98.6) | 79 (75.2) | |
| At least 2 measurements during the study period | 154 (95.7) | 144 (98.6) | 79 (75.2) | |
| Baseline measurement above clinical threshold | 84 (52.2) | 74 (50.7) | 39 (37.1) | |
MME indicates morphine milligram equivalent; MPM, medical pain management; MPP, multidisciplinary pain program; NRS, numeric rating scale; ODI, Oswestry Disability Index; PHQ-9, Patient Health Questionnaire-9; WHT, wearable health technology.